More Business Wire
View Older Stories View Newer Stories-
FPT and Kyushu Financial Group Forge Strategic Partnership to Advance Digital Transformation
-
LTM Named NVIDIA Partner Network ‘Rising Star Consulting Partner of the Year’ at NVIDIA GTC 2026
-
Disaster Relief: U-Haul Offers Help to Kona Storm Victims across Hawaii
-
KKR Forms $310 Million Strategic Partnership with PMI Electro to Scale E-Bus Platform Allfleet
-
Toshiba Releases Photovoltaic-Output Photocoupler for Automotive Equipment
-
EdgeConneX Commences Construction of 200MW AI-Ready Hyperscale Campus in Greater Osaka
-
Faraday Future Announces Executive Share Purchase Initiative to Strengthen Long-Term Value, Act Against Potential Illegal Market Manipulation, and Further Align Interests with Stockholders
-
Coupang NVIDIA Collaboration on “AI Factory” Is Powering the Future of E-Commerce Logistics
-
Kolibri Global Energy Inc. Announces 2025 Proved Developed Reserve Increase of 30% and Year End Earnings Call
-
Bunge Global SA Announces Pricing of $1.2 Billion Senior Notes Offering
-
H&M Development Obtains Site Plan Approval for Class-A Self-Storage Facility in the City of Weston
-
SoFi Responds to Inaccurate Short Seller Report
-
Liz Westcott Appointed Woodside CEO
-
International Green Industry Hall of Fame to Name Eight Inductees in Annual Ceremony at University of Redlands
-
Cizzle Brands Corporation Releases Fiscal Q2 2026 Results
-
unWired Broadband Bridges Digital Divide in Lost Hills, CA Through High-Speed Internet Expansion
-
FCPT Announces Acquisition of a First Watch Property for $2.8 Million
-
Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
-
Recon Analytics Acquires Atom Insights, Expanding Global Device Intelligence
-
Atkore Inc. Announces Participation at Upcoming Investor Conference and Webcast
-
Infinity Natural Resources Announces Pricing of Upsized Offering of $550 Million of 7.625% Senior Notes due 2031
-
Rimini Street Announces Participation in the ROTH Capital Partners 38th Annual Investor Conference
-
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
-
Research Quest Celebrates 10-Year Anniversary and 1 Million Learning Sessions
-
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)
-
Mineros S.A. Appoints New Vice President of Legal Affairs to Drive Its Regional Growth Strategy
-
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
-
PIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Exchange Traded Series
-
PIMCO Canada Corp. Announces Quarterly Distributions for PIMCO Canada Exchange Traded Series
-
Aarvik Therapeutics Showcases Novel ADC Molecules Based On MUTTA™ and AQUALINK™ Platforms at AACR 2026
-
Granite REIT Declares Distribution for March 2026
-
JPMorganChase Declares Common Stock Dividend
-
First Farmers and Merchants Corporation Declares Quarterly Cash Dividend of $0.29 Per Share
-
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 An
-
JPMorganChase to Host First-Quarter 2026 Earnings Call
-
Fifth Third Bancorp Announces Cash Dividends
-
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
-
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)
-
Synthekine Announces AACR 2026 Oral Presentation of Updated Phase 1a/1b Clinical and Translational Data for STK‑012 in First‑Line Nonsquamous NSCLC with Features of Immunotherapy Resistance
-
UnitedHealth Group Announces Earnings Release Date
-
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
-
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
-
Oklo’s Atomic Alchemy Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of its Groves Isotopes Test Reactor
-
SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting
-
Beazer Homes Announces Expansion of Revolving Credit Facility to $525 million
-
Pheast Therapeutics to Present Initial Phase 1a Clinical Data and Two New Preclinical Studies of PHST001, a Novel Anti-CD24 Antibody, at AACR 2026
-
Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026
-
NVIDIA Nemotron Powers Ceramic Supervised Generation to Ground AI Responses at Enterprise Scale
-
Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026


